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Purpose: We present a case of orbital abscess following porous orbital implant infection in a 73-year-old 
woman with rheumatoid arthritis. 
Methods: Just one month after a seemingly uncomplicated enucleation and porous polyethylene (Medpor
Ⓡ) 
orbital implant surgery, implant exposure developed with profuse pus discharge. The patient was unrespon-
sive to implant removal and MRI confirmed the presence of an orbital pus pocket. Despite extirpation of the 
four rectus muscles, inflammatory granulation debridement and abscess drainage, another new pus pocket 
developed. 
Results: After partial orbital exenteration, the wound finally healed well without any additional abscess 
formation. 
Conclusions: A patient who has risk factors for delayed wound healing must be examined thoroughly and 
extreme care such as exenteration must be taken if there is persistent infection.  Korean Journal of Ophthal-
mology 20(4):234-237, 2006
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Infected porous orbital implants are, to date, rare. When 
they occur, implant removal has been the only successful 
treatment modality.
1,2 Several cases of porous implant 
infection have shown that removal of the implant did not 
worsen the progression of orbital infection.
3,4 To our knowl-
edge, this is the first reported case of orbital implant infection 
not controlled with implant removal.
Case Report
A 73-year-old woman presented with purulent conjunctival 
discharge and pain in her left, enucleated eye. She had a 
medical history of oral steroid intake for rheumatoid arthritis 
and antihypertensive medication for several years. She had an 
ocular history of melting necrotizing scleritis, and it was so 
intractable that an enucleation had been performed a month 
previously. After enucleation, a synthetic porous polyethylene 
implant (Medpor
Ⓡ, POREX Surgical Inc., USA, 20 mm in 
diameter) wrapped with sterilized donor sclera was used to 
replace orbital volume. 
A culture of the eye discharge revealed Propionibacterium 
acne, at which time systemic and topical antibiotic medica-
tion was started. Despite massive antibiotic treatment, the 
discharge was still seen from the conjunctival wound, and the 
infection continued to melt the conjunctiva and wrapping 
donor sclera. The Medpor
Ⓡ implant was eventually exposed 
a month after implantation. The patient was diagnosed with 
implant infection and underwent an implant removal.
The wound seemed to recover well, but two months later, 
purulent discharge was again seen from the wound site. 
Magnetic resonance imaging of the left orbit revealed 
myositis of the four rectus muscles, inflammatory granula-
tions, and abscesses around the orbit, especially around the 
optic nerve (Fig. 1). Extirpation of the four rectus muscles, 
removal of underlying inflammatory granulation, and abscess 
drainage were performed, and the wound was then soaked 
with betadine and antibiotic solution.
The wound recovered well, and a month after abscess 
excision, dermo-fat tissue harvested from the inguinal area 
was grafted to orbital defect site. The, graft failed to survive, 
and pus discharge from the wound developed once again. The 
graft was removed a month after implantation, but the 
discharge persisted (Fig. 2). 
Follow-up magnetic resonance imaging two months after 
removal of the dermo-fat graft showed inflammatory granula-
tions and abscess formation in the left orbit (Fig. 3). Out of 
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Fig. 1. T1-weighted,  gadolinium  enhanced  horizontal  magnetic 
resonance imaging of the brain  and orbits, showing myositis  in all 
four  rectus  muscles,  and  an  abscess  pocket  between  the  medial 
wall  and  medial  rectus  muscle  (arrow).
Fig. 2. Profuse  pus  discharge  one  month  after  removal  of  dermo- 
fat  graft.
performed a partial exenteration of the left orbit. In this 
procedure, the skin and orbicularis muscle were dissected and 
removed, and tissue in the orbital apex was taken out of the 
socket (Fig. 4). Microscopic examination of the exenterated 
tissue around the abscess revealed massive inflammation, but 
no bacterial growth was identified in the specimen (Fig. 5). 
Thereafter, the wound healed well without any additional 
inflammation. One and one half years after the final surgery, 
the wound site was well resolved, and no infection or 
inflammation was found (Fig. 6).
Fig. 3. T1  weighted,  gadolinium  enhanced  horizontal  magnetic 
resonance  imaging of  the  brain and  orbits  2 months  after  removal 
of dermo-fat graft. All four rectus muscles were removed. Previous 
abscess  pocket  was  resolved,  but  new  abscess  pocket  developed 
(arrow).
Fig. 4. Partial  exenterated  orbital  tissues  were  removed  from 
socket. 
Discussion
Although implant exposure is the most common of the 
complications reported with various porous orbital implants,
5,6 
implant infection is the most serious because antibiotics are 
often ineffective, and removal may be necessary.
3,6 Not only 
is implant removal traumatizing and destructive to the socket 
tissues, the additional intraconal surgery introduces the risk 
of damage to the extraocular muscles and their nerve supply. 
Exenteration also eliminates the main advantage of the 
porous orbital implant, that is, the potential for improved Korean  J  Ophthalmol  Vol.20,  No.4,  2006
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Fig. 5. Histologic  findings  from  the  inflammatory  tissue  specimen  after  partial  exenteration  shows  active  inflammation 
and  fibrosis.  An  aggregate  of  mature  lymphocytes  is  seen  in  fibrous  tissue  and  collagen  bundles,  but  no  evidence  of 
microorganisms  was  found  (hematoxylin  and  eosin  stain  ×100).
Fig. 6. Final follow-up. The wound site was well resolved, and no 
inflammation  or  signs  of  infection  were  found. 
implant and prosthesis motility, especially when the improved 
implant is coupled with the orbital implant through a peg 
coupling system.
5 Implant infection can often be resolved by 
implant removal. Organisms within a biofilm are difficult to 
eradicate by conventional antimicrobial therapy and can cause 
indolent infections. The presence of bacterial biofilms has 
been demonstrated on many medical devices including intra-
venous catheters, as well as materials relevant to the eye such 
as contact lenses, scleral buckles, suture materials, and intra-
ocular lenses.
7 Many ocular infections occur when such 
prosthetic devices come in contact with or are implanted in 
the eye. When orbital implants are truly infected, these bio-
films render antibiotic therapy ineffective, and removal of the 
implant is necessary. In cases of infected hydroxyapatite 
orbital implants, inflammation treatment is typically successful 
after implant removal and additional surgical repair, such as 
Medpor
Ⓡ impalantation or dermis fat graft.
8 In many cases 
of culture-negative presumed infection, medical antibiotic 
therapy was effective. This case is the first in which infection 
could not be controlled by removal of the orbital implant, or 
even by orbital exenteration including the rectus muscles. 
It is unclear why surgical treatment was unsuccessful in 
this case. Underlying long term steroid treatment for rheu-
matoid arthritis might have caused greater susceptibility to 
infection.
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risk factors for delayed wound-healing must be examined 
thoroughly when there is infection. Extreme care must be 
taken in planning and performing secondary surgery or, as in 
this case, more extensive surgery such as exenteration may 
be required.
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